Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors
Sotio Biotech Inc.
Sotio Biotech Inc.
Pfizer
Ocellaris Pharma, Inc.
Fusion Pharmaceuticals Inc.
Bolt Biotherapeutics, Inc.
Actym Therapeutics, Inc.
Pfizer
Numab Therapeutics AG
University of Virginia
M.D. Anderson Cancer Center
Seagen Inc.
Aminex Therapeutics, Inc.
Rain Oncology Inc
ADC Therapeutics S.A.
ABM Therapeutics Corporation
Pfizer
Atreca, Inc.
Hoffmann-La Roche
Novartis
Duke University
MacroGenics
Incyte Corporation
Seagen Inc.
KitovPharma
Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Daiichi Sankyo
Cambridge University Hospitals NHS Foundation Trust
Tocagen Inc.
National Institutes of Health Clinical Center (CC)
Vanderbilt-Ingram Cancer Center
Novartis
CureOne
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
Rutgers, The State University of New Jersey
National Institutes of Health Clinical Center (CC)
Calando Pharmaceuticals
New Mexico Cancer Research Alliance